Company profile: Synthace
1.1 - Company Overview
Company description
- Provider of a SaaS digital experiment platform for life science R&D that digitizes experiments end-to-end, enabling scientists to design, simulate, run, and analyze reproducible experiments without code. Integrates data and metadata, supports dynamic automation for frequent updates, offers a drag-and-drop workflow builder translating human directions to robot instructions, and DOE tools for media optimization.
Products and services
- Digital Experiment Platform: A SaaS platform that lets scientists design, plan, simulate ahead of time, run, and analyze reproducible experiments without code, integrating data and metadata and executing on lab automation equipment
- Workflow Builder: A no-code drag-and-drop tool that converts human-language directions into complex robot instructions, automating lab processes without custom scripting
- Protocol Reproducibility: A cross-lab capability that captures and controls the true intent of experiments, ensuring reproducibility across different labs, machines, and teams
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synthace
BBK Worldwide
HQ: United States
Website
- Description: Provider of patient recruitment marketing and clinical trial support for the pharmaceutical, biotechnology, and medical device industries, offering strategy and research for trial enrollment, creative recruitment campaigns, targeted outreach across media channels, apps, and influencers, site success services (prescreening, referral management, communications), participant travel logistics with concierge support, and global participant payment reimbursement with instant access to funds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BBK Worldwide company profile →
4Tune Engineering
HQ: Portugal
Website
- Description: Provider of intelligent engineering solutions focused on operational excellence, helping companies decisively improve the entire life-cycle of their products and processes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4Tune Engineering company profile →
Eureka Genomics
HQ: United States
Website
- Description: Provider of Next Generation Sequencing and gene annotation services and diagnostics to detect inherited genetic traits, cancers, and infectious diseases in humans, animals, and crops. Offerings include detection of foreign nucleic acids, sequence data analysis, resequencing and mapping, platform-agnostic genotyping of SNPs, InDels, CNV, methylation, barley and bovine SNP panels, custom NGG assay design, and NGS for CE sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eureka Genomics company profile →
Silicon Therapeutics
HQ: United States
Website
- Description: Provider of fully integrated drug design, research and development using a physics-driven approach coupled to chemistry and biology R&D, with a pipeline including VTAMA (Tapinarof) for plaque psoriasis; Batoclimab for autoimmune diseases (MG, TED, CIDP, Graves' Disease); IMVT-1402 (Phase 1) subcutaneous injection; Brepocitinib for dermatomyositis and non-infectious uveitis (Phase 3 for some applications); and Namilumab for sarcoidosis (Phase 2).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Silicon Therapeutics company profile →
Trialbee
HQ: Sweden
Website
- Description: Provider of vendor-agnostic patient recruitment solutions for the pharmaceutical industry, featuring Honey Platform to centralize recruitment with transparency, actionable data insights and ROI reporting; Precision Recruitment using data-driven profiling, hyper-targeted digital outreach and medical secondary screening to pre-qualify clinical trial patients; and an Omnichannel Network creating diverse patient pathways via curated partners.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trialbee company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synthace
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synthace
2.2 - Growth funds investing in similar companies to Synthace
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synthace
4.2 - Public trading comparable groups for Synthace
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →